{
    "clinical_study": {
        "@rank": "83958", 
        "arm_group": {
            "arm_group_label": "Treatment", 
            "arm_group_type": "Experimental", 
            "description": "gastric band"
        }, 
        "brief_summary": {
            "textblock": "This study is to investigate the use the adjustable gastric band for the treatment of\n      obesity in adolescents."
        }, 
        "brief_title": "Use of Adjustable Gastric Band in Adolescents", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "OBESITY", 
        "condition_browse": {
            "mesh_term": "Obesity"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        BMI: Female: \u2265 27 - \u2265 33 Male      \u2265 26 - \u2265 30.5\n\n        Exclusion Criteria:\n\n          -  \u2022Hypertension: Systolic blood pressure (SBP) of 140 mm Hg\n\n               -  Hyperlipidemia:  hyperlipidemia depends on\n\n               -  Obstructive Sleep Apnea:\n\n               -  Metabolic Syndrom: The presence of any three of the following: abdominal obesity\n                  - dimensons for children? triglycerides -cholesterol -\n\n          -  fasting glucose\n\n          -  blood pressure\n\n               -  overweight\n\n               -  Non-surgical means of weight reduction failure of\n\n               -  Significant psychopathology (absence of ) that could limit the subject's ability\n                  to understand the procedure, comply with medical, surgical, and/or behavioral\n                  recommendations, as documented during screening assessment;\n\n               -  Agrees to refrain from any type of reconstructive surgery that would affect body\n                  weight such as abdominal lipoplasty or liposuction, mammoplasty, or removal of\n                  excess skin for three years following SAGB placement; and\n\n               -  Candidate for surgical weight loss intervention (i.e., meets accepted health\n                  criteria for major surgery."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "12 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01882049", 
            "org_study_id": "IDE#G100290"
        }, 
        "intervention": {
            "arm_group_label": "Treatment", 
            "description": "gastric band", 
            "intervention_name": "REALIZE (ETHICON)", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "June 17, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Minneapolis", 
                    "country": "United States", 
                    "state": "Minnesota", 
                    "zip": "55414"
                }, 
                "name": "University of Minnesota"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Use of the REALIZE\u2122 Adjustable Gastric Band (Model 2200-X) in Adolescents", 
        "overall_contact": {
            "email": "oienx003@umn.edu", 
            "last_name": "Danette Oien", 
            "phone": "612 625 8413"
        }, 
        "overall_contact_backup": {
            "email": "willi004@umn.edu", 
            "last_name": "Stanley Williams, PhD", 
            "phone": "612 625 3265"
        }, 
        "overall_official": {
            "affiliation": "University of Minnesota - Clinical and Translational Science Institute", 
            "last_name": "Sayeed Ikrammudin, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Reduction in percent of excess weight loss (%EWL).", 
            "measure": "Weight loss", 
            "safety_issue": "No", 
            "time_frame": "Monthly up to one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01882049"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Minnesota - Clinical and Translational Science Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Minnesota - Clinical and Translational Science Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}